FZD4 and neoplasm: Diverse members of the GPCR superfamily have been shown to mediate angiogenic signals in cancer, suggesting that the manipulation of GPCR signaling may be included among the novel therapeutic strategies to halt angiogenesis in the tumor microenvironment [131,132,133].